A novel inhibitor of class IIa histone deacetylases attenuates collagen-induced arthritis.
Eunice K PoonLigong LiuKai-Chen WuJunxian LimMatthew J SweetRink-Jan LohmanAbishek IyerDavid P FairliePublished in: British journal of pharmacology (2024)
A novel inhibitor of class IIa HDACs has been shown to have an anti-inflammatory and anti-arthritic profile distinct from current therapies. It is efficacious in reducing macrophage infiltration and joint inflammation in a chronic model of rat arthritis.